{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:24:01Z","timestamp":1792265041359,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11060-023-04413-4","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:02:38Z","timestamp":1698411758000},"page":"63-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients"],"prefix":"10.1007","volume":"165","author":[{"given":"Eric J.","family":"Lehrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atulya A.","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ozair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gurewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kondziolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Niranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishuo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Dade","family":"Lunsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Deibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Malouff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ruiz-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Zada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Picozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Franzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Attuati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju R.","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-che","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem R.","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad G.","family":"Rusthoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Dickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Trifiletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmeet S.","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"4413_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/noajnl\/vdaa041","volume":"2","author":"R Singh","year":"2020","unstructured":"Singh R, Stoltzfus KC, Chen H, Louie AV, Lehrer EJ, Horn SR, Palmer JD, Trifiletti DM, Brown PD, Zaorsky NG (2020) Epidemiology of synchronous brain metastases. Neurooncol Adv. 2:41. https:\/\/doi.org\/10.1093\/noajnl\/vdaa041","journal-title":"Neurooncol Adv."},{"key":"4413_CR2","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","volume":"33","author":"X Lin","year":"2015","unstructured":"Lin X, DeAngelis LM (2015) Treatment of brain metastases. J Clin Oncol 33:3475\u20133484. https:\/\/doi.org\/10.1200\/JCO.2015.60.9503","journal-title":"J Clin Oncol"},{"key":"4413_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745\u2013751. https:\/\/doi.org\/10.1016\/s0360-3016(96)00619-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","volume":"280","author":"RA Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485\u20131489. https:\/\/doi.org\/10.1001\/jama.280.17.1485","journal-title":"JAMA"},{"key":"4413_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500. https:\/\/doi.org\/10.1056\/NEJM199002223220802","journal-title":"N Engl J Med"},{"key":"4413_CR6","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"P Mulvenna","year":"2016","unstructured":"Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, Moore B, Brisbane I, Ardron D, Holt T, Morgan S, Lee C, Waite K, Bayman N, Pugh C, Sydes B, Stephens R, Parmar MK, Langley RE (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 388:2004\u20132014. https:\/\/doi.org\/10.1016\/S0140-6736(16)30825-X","journal-title":"Lancet"},{"key":"4413_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"key":"4413_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316:401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"4413_CR9","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gumus M, Mazieres J, Hermes B, Cay Senler F, Csoszi T, Fulop A, Rodriguez-Cid J, Wilson J, Sugawara S, Kato T, Lee KH, Cheng Y, Novello S, Halmos B, Li X, Lubiniecki GM, Piperdi B, Kowalski DM, Investigators K (2018) Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med 379:2040\u20132051. https:\/\/doi.org\/10.1056\/NEJMoa1810865","journal-title":"N Engl J Med"},{"key":"4413_CR10","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, Csoszi T, Fulop A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O\u2019Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR, Investigators K (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375:1823\u20131833. https:\/\/doi.org\/10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"key":"4413_CR11","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC, Investigators K (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378:2078\u20132092. https:\/\/doi.org\/10.1056\/NEJMoa1801005","journal-title":"N Engl J Med"},{"key":"4413_CR12","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3171\/2015.4.JNS1573","volume":"124","author":"HS Park","year":"2016","unstructured":"Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB (2016) Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. J Neurosurg 124:1018\u20131024. https:\/\/doi.org\/10.3171\/2015.4.JNS1573","journal-title":"J Neurosurg"},{"key":"4413_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103054","author":"EJ Lehrer","year":"2018","unstructured":"Lehrer EJ, McGee HM, Peterson JL, Vallow L, Ruiz-Garcia H, Zaorsky NG, Sharma S, Trifiletti DM (2018) Stereotactic radiosurgery and immune checkpoint inhibitors in the management of brain metastases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19103054","journal-title":"Int J Mol Sci"},{"key":"4413_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-020-03427-6","volume":"151","author":"EJ Lehrer","year":"2021","unstructured":"Lehrer EJ, McGee HM, Sheehan JP, Trifiletti DM (2021) Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases. J Neurooncol 151:75\u201384. https:\/\/doi.org\/10.1007\/s11060-020-03427-6","journal-title":"J Neurooncol"},{"key":"4413_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","volume":"130","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson J, Brown PD, Sheehan JP, Quinones-Hinojosa A, Zaorsky NG, Trifiletti DM (2019) Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: an international meta-analysis of individual patient data. Radiother Oncol 130:104\u2013112. https:\/\/doi.org\/10.1016\/j.radonc.2018.08.025","journal-title":"Radiother Oncol"},{"key":"4413_CR16","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773\u20133784. https:\/\/doi.org\/10.1200\/JCO.20.01255","journal-title":"J Clin Oncol"},{"key":"4413_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"4413_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000866","author":"EJ Lehrer","year":"2021","unstructured":"Lehrer EJ, Stoltzfus KC, Jones BM, Gusani NJ, Walter V, Wang M, Trifiletti DM, Siva S, Louie AV, Zaorsky NG (2021) Trends in diagnosis and treatment of metastatic cancer in the United States. Am J Clin Oncol. https:\/\/doi.org\/10.1097\/COC.0000000000000866","journal-title":"Am J Clin Oncol"},{"key":"4413_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11864-021-00854-z","volume":"22","author":"BA Vellayappan","year":"2021","unstructured":"Vellayappan BA, McGranahan T, Graber J, Taylor L, Venur V, Ellenbogen R, Sloan AE, Redmond KJ, Foote M, Chao ST, Suh JH, Chang EL, Sahgal A, Lo SS (2021) Radiation necrosis from stereotactic radiosurgery-how do we mitigate? Curr Treat Options Oncol 22:57. https:\/\/doi.org\/10.1007\/s11864-021-00854-z","journal-title":"Curr Treat Options Oncol"},{"key":"4413_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","volume":"4","author":"AM Martin","year":"2018","unstructured":"Martin AM, Cagney DN, Catalano PJ, Alexander BM, Redig AJ, Schoenfeld JD, Aizer AA (2018) Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation. JAMA Oncol 4:1123\u20131124. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3993","journal-title":"JAMA Oncol"},{"key":"4413_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.01.017","author":"EJ Lehrer","year":"2023","unstructured":"Lehrer EJ, Kowalchuk RO, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, Hwang L, Yu C, Zada G, Patel S, Deibert CP, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Harmsen WS, Jones BM, Sharma S, Ahluwalia MS, Sheehan JP, Trifiletti DM (2023) Concurrent administration of immune checkpoint inhibitors and single fraction stereotactic radiosurgery in patients with non-small cell lung cancer, melanoma, and renal cell carcinoma brain metastases is not associated with an increased risk of radiation necrosis over non-concurrent treatment: an international multicenter study of 657 patients. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573\u2013577. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med"},{"key":"4413_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34087","author":"EJ Lehrer","year":"2022","unstructured":"Lehrer EJ, Gurewitz J, Bernstein K, Patel D, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Malouff TD, Ruiz-Garcia H, Patel S, Bonney PA, Hwang L, Yu C, Zada G, Mathieu D, Trudel C, Prasad RN, Palmer JD, Jones BM, Sharma S, Fakhoury KR, Rusthoven CG, Deibert CP, Picozzi P, Franzini A, Attuati L, Lee CC, Yang HC, Ahluwalia MS, Sheehan JP, Trifiletti DM (2022) Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: an international multicenter study. Cancer. https:\/\/doi.org\/10.1002\/cncr.34087","journal-title":"Cancer"},{"key":"4413_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2015.01.004","volume":"92","author":"AP Kiess","year":"2015","unstructured":"Kiess AP, Wolchok JD, Barker CA, Postow MA, Tabar V, Huse JT, Chan TA, Yamada Y, Beal K (2015) Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Int J Radiat Oncol Biol Phys 92:368\u2013375. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ (2018) Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys 100:916\u2013925. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/s0360-3016(99)00513-1","volume":"46","author":"JC Flickinger","year":"2000","unstructured":"Flickinger JC, Kondziolka D, Lunsford LD, Kassam A, Phuong LK, Liscak R, Pollock B (2000) Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys 46:1143\u20131148. https:\/\/doi.org\/10.1016\/s0360-3016(99)00513-1","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","volume":"103","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, Chao ST, Sheehan JP, Trifiletti DM (2019) Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103:618\u2013630. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","volume":"110","author":"MT Milano","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A, Soltys SG, Moiseenko V, Redmond KJ, Yorke E, Sahgal A, Xue J, Mahadevan A, Muacevic A, Marks LB, Kleinberg LR (2021) Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain. Int J Radiat Oncol Biol Phys 110:68\u201386. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48. https:\/\/doi.org\/10.1186\/1748-717X-6-48","journal-title":"Radiat Oncol"},{"key":"4413_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","volume":"86","author":"G Minniti","year":"2013","unstructured":"Minniti G, Esposito V, Clarke E, Scaringi C, Lanzetta G, Salvati M, Raco A, Bozzao A, Maurizi Enrici R (2013) Multidose stereotactic radiosurgery (9 Gy x 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 86:623\u2013629. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR31","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","volume":"95","author":"G Minniti","year":"2016","unstructured":"Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, Osti M, Enrici RM, Esposito V (2016) Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95:1142\u20131148. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR32","unstructured":"Services USDoHH Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0."},{"key":"4413_CR33","unstructured":"Team R (2015) RStudio: Integrated Development Environment for R."},{"key":"4413_CR34","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391\u20134400. https:\/\/doi.org\/10.1002\/sim.7501","journal-title":"Stat Med"},{"key":"4413_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijrobp.2009.06.006","volume":"77","author":"BJ Blonigen","year":"2010","unstructured":"Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996\u20131001. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijrobp.2005.07.980","volume":"64","author":"T Korytko","year":"2006","unstructured":"Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419\u2013424. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.07.980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR37","doi-asserted-by":"publisher","DOI":"10.3171\/2022.7.JNS22752","author":"EJ Lehrer","year":"2022","unstructured":"Lehrer EJ, Ahluwalia MS, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, Hwang L, Yu C, Zada G, Patel S, Deibert CP, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Jones BM, Green S, Sheehan JP, Trifiletti DM (2022) Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients. J Neurosurg. https:\/\/doi.org\/10.3171\/2022.7.JNS22752","journal-title":"J Neurosurg"},{"key":"4413_CR38","doi-asserted-by":"crossref","unstructured":"Tom MC, DiFilippo F, Smile T, Jones SE, Suh JH, Murphy ES, Yu JS, Mohammadi AM, Barnett GH, Angelov L, Huang SS, Wu G, Johnson S, Obucowski N, Ahluwalia M, Peereboom D, Stevens G, Chao ST (2021) 18F-Fluciclovine PET\/CT to Distinguish Radiation Necrosis From Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery: Results of a Prospective Pilot Study. 63rd Annual Meeting for the American Society of Radiation Oncology. International Journal of Radiation Oncology Biology Physics, Chicago, IL","DOI":"10.1016\/j.ijrobp.2021.07.089"},{"key":"4413_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/neuonc\/noz147","volume":"22","author":"N Galldiks","year":"2020","unstructured":"Galldiks N, Kocher M, Ceccon G, Werner JM, Brunn A, Deckert M, Pope WB, Soffietti R, Le Rhun E, Weller M, Tonn JC, Fink GR, Langen KJ (2020) Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression. Neuro Oncol 22:17\u201330. https:\/\/doi.org\/10.1093\/neuonc\/noz147","journal-title":"Neuro Oncol"},{"key":"4413_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1158\/2326-6066.CIR-15-0160","volume":"4","author":"JV Cohen","year":"2016","unstructured":"Cohen JV, Alomari AK, Vortmeyer AO, Jilaveanu LB, Goldberg SB, Mahajan A, Chiang VL, Kluger HM (2016) Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment. Cancer Immunol Res 4:179\u2013182. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0160","journal-title":"Cancer Immunol Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04413-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04413-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04413-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:11:47Z","timestamp":1699614707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04413-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04413-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Lunsford is a stockholder in Elekta AB, Stockholm, Sweden; Dr. Trifiletti reports institutional support from Novocure Ltd and consulting for Boston Scientific Corporation for unrelated research. Dr. Palmer reports personal fees from Varian Medical System, Consulting for Huron Consulting group, Advisory board for Novocure, research grant funding from Kroger, NIH R702 grant, outside submitted work. Dr. Kondziolka holds research grants from Brainlab that are not related to this work. Dr. Ahluwalia is a consultant for AnHeart therapeutics, Bayer, Novocure, Kiyatec, Insightec, GSK, Xoft, Nuvation, Cellularity, SDP Oncology, Apollomics, Prelude, Janssen, Tocagen, Voyager Therapeutics, Viewray, Caris Lifesciences, Pyramid Biosciences, Varian Medical Systems, and Carin Therapeutics. Dr. Ahluwalia is on the scientific advisory board for Cairn Therapautics, Pyramid Biosciences. \u00a0Dr. Ahluwalia has research grants from Seagen. He is a consultant for\u00a0Bayer, Novocure, Kiyatec, Insightec, GSK, Xoft, Nuvation, Cellularity, SDP Oncology, Apollomics, Prelude, Janssen, Tocagen, Voyager Therapeutics, Viewray, Caris Lifesciences, Pyramid Biosciences, Varian Medical Systems, Cairn Therapeutics, Anheart Therapeutics, Theraguix, Menarini Ricerche, Sumitomo Pharma Oncology, Autem therapeutics, GT Medical Technologies. He serves on the scientific advisory board for\u00a0Cairn Therapeutics, Pyramid Biosciences, Modifi biosciences., Bugworks. He is a shareholder in\u00a0Mimivax, Cytodyn, MedInnovate Advisors LLC, Trisalus Lifesciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}